Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy

.

Source: Artificial Cells, Blood Substitutes, and Biotechnology - July 23, 2018 Category: Biotechnology Authors: Mahdie Hemati Fateme Haghiralsadat Fatemeh Yazdian Farzaneh Jafari Ali Moradi Zahra Malekpour-Dehkordi Source Type: research